Citation Impact
Citing Papers
Pten Deficiency in Melanocytes Results in Resistance to Hair Graying and Susceptibility to Carcinogen-Induced Melanomagenesis
2008 StandoutNobel
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
2017 Standout
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
2012 StandoutNobel
Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
2012
Basal Cell Carcinomas in Mice Overexpressing Sonic Hedgehog
1997 StandoutScience
Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma
2014
Nevoid basal cell carcinoma syndrome
1984
Basal-Cell Carcinoma
2005
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma
1989
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Topical carmustine (BCNU) for cutaneous T cell lymphoma: A 15-year experience in 143 patients
1990
BRAFE600-associated senescence-like cell cycle arrest of human naevi
2005 StandoutNature
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
TLR based therapeutics
2011
Prognostic factor analysis in mycosis fungoides/Sézary syndrome
1999
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
2005
Interactions between the tumor suppressor p53 and immune responses
2012
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Type I interferons in infectious disease
2015 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients
2012
Role of Drosophila IKKγ in a Toll-independent antibacterial immune response
2000 StandoutNobel
Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7—challenging the concept of dysplastic nevi as precursor lesions?
2010
mTOR at the nexus of nutrition, growth, ageing and disease
2020 Standout
Angiogenesis in health and disease
2003 Standout
Mycosis Fungoides
2000
Assembly and localization of Toll-like receptor signalling complexes
2014
Missing Pieces in the NF-κB Puzzle
2002 Standout
Nuclear factor-κB in cancer development and progression
2006 StandoutNature
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
2005 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Prognostic Clinicopathologic Factors in Cutaneous T-cell Lymphoma
1991
Hemangiomas: Evaluation and Treatment
2001
The cornified envelope: a model of cell death in the skin
2005 Standout
Distinct Sets of Genetic Alterations in Melanoma
2005 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
2009 Standout
Educational Levels of Hospital Nurses and Surgical Patient Mortality
2003 Standout
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
2013 Standout
Female Mice Heterozygous for IKKγ/NEMO Deficiencies Develop a Dermatopathy Similar to the Human X-Linked Disorder Incontinentia Pigmenti
2000
Inhibition of NF-κB Activation by Arsenite through Reaction with a Critical Cysteine in the Activation Loop of IκB Kinase
2000 StandoutNobel
Malignant melanoma: modern black plague and genetic black box
1998
NF-κB regulation in the immune system
2002 Standout
Cancer immunotherapy
2012
Cancer immunotherapy comes of age
2011 StandoutNature
Human Papillomavirus Types 16 E6 and E7 Contribute Differently to Carcinogenesis
2000
Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy
1992
Signaling to NF-κB
2004 Standout
Points of control in inflammation
2002 StandoutNature
Autoimmunity against desmosomal cadherins in pemphigus
1999
Cowden Syndrome and the PTEN Hamartoma Tumor Syndrome: Systematic Review and Revised Diagnostic Criteria
2013
Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting
2001
Clinical relevance of tumour-associated macrophages
2022
NF-κB at the crossroads of life and death
2002 Standout
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
1997
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
A mutation of Ikbkg causes immune deficiency without impairing degradation of IκBα
2010 StandoutNobel
Toxic Potential of Materials at the Nanolevel
2006 StandoutScience
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
1987 Standout
Cutaneous T Cell Lymphoma
1986
Regulation and Function of NF-κB Transcription Factors in the Immune System
2009 Standout
Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.
2000
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Lymph node biopsy in mycosis fungoides
1981
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Four faces of cellular senescence
2011 Standout
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
Skin as a route of exposure and sensitization in chronic beryllium disease.
2003
The effect of health care working conditions on patient safety.
2003
Using observational data from registries to compare treatments: The fallacy of omnimetrics
1984
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
2017
Nevoid Basal Cell Carcinoma Syndrome
1995
Prognostic variables in mycosis fungoides
1981
Suppression of the Malignant Phenotype of Melanoma Cells by Anti-Oncogene Ribozymes
1996
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
1996 StandoutScience
The Immunology of Mycobacterial Infections
1982
Immune Therapy for Cancer
2008
Clinical Staging for Cutaneous T-Cell Lymphoma
1984
Prospective Staging Evaluation of Patients with Cutaneous T-Cell Lymphomas
1980
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
2005 Standout
Presentation of mycobacterial antigens by human dendritic cells: lack of transfer from infected macrophages
1993 StandoutNobel
Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells
2006
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
2007 Standout
Works of Loren E. Golitz being referenced
Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.
1979
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies
2004
The specialty of the treating physician affects the likelihood of tumor-free resection margins for basal cell carcinoma: Results from a multi-institutional retrospective study
2001
Sclerotic fibromas of the skin
1989
Comparison of In Vivo and In Vitro Measures of Beryllium Sensitization
1997
Eosinophilic and neutrophilic spongiosis: Clues to the diagnosis of immunobullous diseases and other inflammatory disorders
1996
RAS Mutations in Human Melanoma: A Marker of Malignant Progression
1994
Diffuse Neonatal Hemangiomatosis
1986
Leprosy in a Vietnamese Adoptee
1980
Nevoid Basal Cell Carcinoma Syndrome
1980
Differential Diagnosis in Dermatopathology II
1989
Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard
1982
Intraepidermal Neutrophilic IgA Dermatosis
1985